Wasatch Health Announces Structured Capital Fund

July 22, 2025 11:00 AM

Wasatch Health announces the launch of its Structured Capital Fund, a milestone that builds on the firm's recent rebrand and strategic integration with the Wasatch Group's healthcare portfolio. This new Fund underscores Wasatch Health's growing capabilities and continued commitment to support companies that improve and extend human life.The Structured Capital fund will raise up to $150 million and focus on providing flexible, minimally dilutive...

Read more

Aspire Biopharma Holdings, Inc. to Launch its BUZZ BOMB Pre-Workout Supplement at FitCon and FitExpo, Two of the Largest Fitness Conventions in the World

July 22, 2025 10:45 AM

Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) ("Aspire" or the "Company"), developer of a multi-faceted patent-pending supplement delivery technology, today announced it plans to launch its newsublingual pre-workout supplement, BUZZ BOMB™, at FitCon and FitExpo, two of the largest fitness conventions held annually in Salt Lake City, Utah (August 1-2) and Anaheim, CA, (August 2-3), respectively.Featuring 50mg of caffeine and designed to support...

Read more

Viemed Healthcare Announces Second Quarter 2025 Earnings Conference Call Details

July 22, 2025 9:00 AM

Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), an in-home clinical care provider of post-acute respiratory healthcare equipment and services in the United States, today announced that it will host its Second Quarter 2025 Earnings Conference Call on Thursday, August 7, 2025, at 11:00 a.m. EDT.Interested parties may participate in the call by dialing:(877) 407-6176 (US Toll-Free)+1 (201) 689-8451 (International)Live Audio...

Read more

RapidClaims Earns Top Ranking in 2025 Black Book(TM) Survey for AI-Powered Claims Automation Among Physician Groups

July 22, 2025 9:00 AM

Black Book Research, the independent healthcare technology research and survey firm, today released the results of its 2025 survey on AI-powered claims automation platforms, naming RapidClaims the top-rated solution for physician practices and group providers. The results reflect evaluations collected from 2,229 verified users of claims automation tools across ambulatory care settings.RapidClaims achieved the highest overall performance across...

Read more

Alta AI Named Exclusive Dental Voice Technology Partner for Dr. Scott Leune's Practice Mastery

July 22, 2025 9:00 AM

Alta AI, dentistry's leading voice technology platform, announced an exclusive partnership with Dr. Scott Leune's Practice Mastery, the top dental coaching group founded by renowned dentist and entrepreneur Dr. Scott Leune. Through this partnership, Alta AI will serve as the exclusive provider of voice-driven charting, notes, and communication tools across Practice Mastery's nationwide network of high-performing practices."Alta AI is changing...

Read more

OncoveryCare Welcomes Dr. Catherine Alfano as Chief Product & Strategy Officer to Build the Future of Survivorship Care

July 22, 2025 9:00 AM

OncoveryCare, which delivers virtual, whole-person care to cancer survivors, today announced that Catherine M. Alfano, PhD, has joined as Chief Product & Strategy Officer. Dr. Alfano, a renowned expert in cancer survivorship, brings a wealth of experience in clinical innovation and research. In her new role, she will help evolve OncoveryCare's novel survivorship model and scale it across the oncology ecosystem."I am thrilled at the opportunity...

Read more

Exxel Pharma Participates in the Virtual Investor "What’s Your Story" Summer Spotlight On-Demand Conference

July 22, 2025 8:45 AM

Exxel Pharma ("Exxel" or the "Company"), a pharmaceutical company dedicated to developing novel therapeutics for the treatment of neuronal hypersensitivity disorders, today announced Soren Mogelsvang PhD, President and Chief Executive Officer and Founder of Exxel, participated in the Virtual Investor "What's Your Story" Summer Spotlight On-Demand Conference. As part of the event, Dr. Mogelsvang dove deeper into his dedication to the Company,...

Read more

CNS Pharmaceuticals to Participate in the Virtual Investor "What’s Your Story" Summer Spotlight On-Demand Conference

July 22, 2025 8:45 AM

CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, today announced that John Climaco, Chief Executive Officer of CNS Pharmaceuticals, participated in the Virtual Investor "What's Your Story" Summer Spotlight On-Demand Conference.As part of the event, Mr. Climaco dove deeper...

Read more

iTolerance, Inc. Participates in the Virtual Investor "What’s Your Story" Summer Spotlight On-Demand Conference

July 22, 2025 8:45 AM

iTolerance, Inc. ("iTolerance" or the "Company"), a biotechnology company focused on the development of innovative regenerative medicines, today announced that Dr. Anthony Japour, Chief Executive Officer of iTolerance, participated in the Virtual Investor "What's Your Story" Summer Spotlight On-Demand Conference.As part of the event, Dr. Japour dove deeper into his dedication to the Company, how he got to where he is today and provided insight...

Read more

Unibar Corporation Granted European Patent for CapsiClear, a Groundbreaking Eye Health Ingredient

July 22, 2025 6:30 AM

Unibar Corporation, a global innovator in science-backed dietary supplement ingredients, is proud to announce the granting of a new European patent for CapsiClear™, its flagship eye health ingredient derived from Capsicum annum extract. The patent was officially granted on July 2, 2025, marking a major milestone in the company's expansion of its proprietary ingredient platform into international markets.CapsiClear™ is a carotenoid standardized...

Read more

neurocare group AG Welcomes Simon Hörauf as Chief Platform Officer

July 22, 2025 6:00 AM

neurocare group AG ("neurocare" or the "Company"), a best practice platform for mental health and performance, is pleased to announce the appointment of Simon Hörauf as Chief Platform Officer of the company, effective July 2025.Simon Hörauf is a design leader with more than 25 years of experience across brand and product domains. He has helped diverse organizations-from startups to federal agencies and global brands like Porsche, Qantas, BMW,...

Read more

Wel-Bloom Biotech Launches Wel-ROS6. Black Crystal Roselle Sparks a Surge in High-Concentration Anthocyanins

July 22, 2025 5:30 AM

Taiwan's leading jelly supplement manufacturer, Wel-Bloom Biotech, recently co-hosted an anthocyanin-focused seminar with LEARN EATiNG, one of the most renowned nutritionist teams in Taiwan. The event highlighted trending international ingredients alongside Taiwan's own Black Crystal Roselle. Attracting around 300 nutrition professionals both online and onsite, the seminar reflected strong industry interest and high expectations for the future...

Read more

Marijuana Rescheduling: The DEA's Dirty Little Cannabis Secret: Meet the 800-Pound Marijuana Gorilla

July 22, 2025 5:00 AM

For decades, the Drug Enforcement Administration has quietly presided over a regulatory disaster-one so entrenched, so damaging, and so absurd that it's hard to believe it hasn't yet become a national scandal.Its name? The DEA Quota System.Its impact? The systematic sabotage of America's cannabis research ecosystem.Its enabler? A bureaucracy that protects monopolies, not medicine. The 800 lb. Gorilla in the Room: DEA Quotas WeaponizedThe DEA...

Read more

CASI Pharmaceuticals Appoints David Cory as Chief Executive Officer to Lead U.S. Company Focused on Clinical Development of CID-103, a Potential Best in Class Anti-CD38 Program

July 21, 2025 4:05 PM

CASI Pharmaceuticals, Inc. (NASDAQ:CASI), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products, today announced the appointment of David Cory as Chief Executive Officer and a member of the Board of Directors. Wei-Wu He, Ph.D. will step down as the CEO and will remain as Executive Chairman of the Board of Directors."We are pleased to welcome David as our new CEO...

Read more

SMP Nutra Officially Cuts Ribbon For Their New Headquarters In Florida

July 21, 2025 9:00 AM

SMP Nutra, a leading contract manufacturer of dietary supplements, has officially celebrated the grand opening of its new headquarters in Largo, Florida. The company has successfully completed its headquarters relocation from Long Island, New York, to a state‑of‑the‑art facility that has more than 100,000 square feet.The new headquarters represent a significant milestone in SMP Nutra's growth. Designed to support increased production capacity...

Read more

Endo UV Tech, Inc. Secures fourth U.S. Patent for UV Laser-Based Medical Device Innovation

July 21, 2025 9:00 AM

EndoUVTech is a medical device innovator specializing in UV laser-based surgical technologies for blood clots in the brain, today announced that the United States Patent and Trademark Office has issued a fourth U.S. Patent, No. 12,357,383, titled "Device and Method for Dilation of a Tubular Anatomical Structure." This newly granted patent further strengthens EndoUVTech's growing intellectual property portfolio and global patent coverage.The...

Read more

LeBron Jersey Fetches $242K as MDCE's Subsidiaries Hit Growth Stride

July 21, 2025 9:00 AM

Medical Care Technologies Inc. (OTC Pink:MDCE) is pleased to announce that its wholly owned subsidiary, Infinite Auctions, has completed the sale of a LeBron James 2014 NBA Finals Game-Worn Miami Heat Jersey for $242,400. The jersey was worn by James in Game 4 of the 2014 NBA Finals, marking his final home game as a member of the Miami Heat.Authenticated by MeiGray, Upper Deck Authenticated, and Real Game Used (RGU)-MDCE's AI-based...

Read more

Champions Oncology to Announce Fourth Quarter and Year-End Financial Results on Wednesday, July 23, 2025

July 21, 2025 8:30 AM

Champions Oncology, Inc. (CSBR), a global preclinical and clinical research services provider that offers end-to-end oncology solutions, will report its financial and operational results for the quarter and year ended April 30, 2025, on Wednesday, July 23, 2025, after market close. The company will host a conference call to discuss the results that day at 4:30 P.M. EDT (1:30 P.M. PDT). To join the call dial 888-506-0062 (Domestic) or...

Read more

Protagonist Announces Submission of NDA for First Icotrokinra U.S. FDA Approval Aiming to Revolutionize Treatment Paradigm for Adults and Adolescents with Plaque Psoriasis

July 21, 2025 8:05 AM

Protagonist Therapeutics, Inc. ("Protagonist" or the "Company") announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) by Johnson & Johnson seeking the first approval of icotrokinra, a first-in-class investigational targeted oral peptide for the treatment of adults and pediatric patients 12 years of age and older with moderate to severe plaque psoriasis (PsO). Icotrokinra is uniquely designed to...

Read more

Measles Now Has a Drug - NV-387 Broad-Spectrum Antiviral Successful in Animal Studies, says NanoViricides

July 21, 2025 6:30 AM

NanoViricides, Inc., a publicly traded company (NYSE Amer.: NNVC ) (the "Company"), and a clinical stage, leading global pioneer in the development of broad-spectrum antivirals based on host-mimetic nanomedicine technology that viruses cannot escape, announced that it has achieved significant success in developing a drug against Measles.Strong antiviral effectiveness against Measles virus was found for NV-387, the Company's broad-spectrum drug...

Read more